This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
MetLife (MET) Q1 Earnings Top Estimates, Revenues Rise Y/Y
by Zacks Equity Research
MetLife's (MET) Q1 rides high on improved performances across the U.S., Asia, EMEA and MetLife Holdings Segments plus a favorable impact of the reformed U.S. tax law.
Insurers' Q1 Earnings Due on May 2: AIG, LNC, MET, PRU, XL
by Zacks Equity Research
Insurance stocks in the first quarter are likely to benefit from a positive operating environment, fundamental strength of insurers and a lower tax rate.
MetLife (MET) Q1 Earnings to Buoy on Revenue Growth
by Zacks Equity Research
MetLife (MET) Q1 earnings should see upside from higher revenues in property and casualty business, a low tax rate, high investment income.
The Zacks Analyst Blog Highlights: Facebook, UnitedHealth, Pfizer, McDonald's and MetLife
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Facebook, UnitedHealth, Pfizer, McDonald's and MetLife
MetLife Bolsters Operations in China With Tencent's WeSure
by Zacks Equity Research
MetLife's (MET) partnerships aim at delivering high quality products to customers at lower cost along with convenience and ease as a bonus.
Top Research Reports for UnitedHealth, Morgan Stanley & Anheuser-Busch
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth (UNH), Morgan Stanley (MS) and Anheuser-Busch (BUD).
Top Analyst Reports for Bristol-Myers, Honda & Danaher
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Bristol-Myers (BMY), Honda (HMC), and Danaher (DHR).
MetLife (MET) Q4 Earnings Beat, Revenues Miss Estimates
by Zacks Equity Research
Robust EMEA and Latin America segments aid MetLife (MET) in Q4. However, a dull performance at U.S., Asia and MetLife Holdings partially offsets this upside.
Why Earnings Season Could Be Great for MetLife (MET)
by Zacks Equity Research
MetLife (MET) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Top Research Reports for Apple, JPMorgan & AbbVie
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Apple (AAPL), JPMorgan (JPM) and AbbVie (ABBV).
Arthur J. Gallagher's Buyout to Fortify Water Utility Insurance
by Zacks Equity Research
Arthur J. Gallagher (AJG) continues its inorganic growth strategy on the back of AquaSurance acquisition.
Hartford Q4 Earnings Might be Drained by Tax Act & Cat Loss
by Zacks Equity Research
Hartford (HIG) expects the recent tax law and catastrophe losses to impact its fourth-quarter 2017 results adversely. However, the company remains optimistic about the long-term benefits from it.
Is MetLife (MET) a Great Stock for Value Investors?
by Zacks Equity Research
Let's see if MetLife Inc. (MET) stock is a good choice for value-oriented investors right now from multiple angles.
Fed Hikes Rates: Pick 6 Value Stocks from Insurance Industry
by Zacks Equity Research
Amid an improving macro backdrop, we select six value stocks with strong fundamentals from the insurance industry for better returns.
Fed Hikes Rate: 4 Stocks to Add Value to Your Portfolio
by Zacks Equity Research
The Fed, who have chalked out a detailed plan to shrink $4.5 trillion portfolio of Treasury bonds and mortgage-backed securities, continue to advocate three more hikes next year.
CNO Financial Grows on Solid Cash Position, High Debt Hurts
by Zacks Equity Research
Although CNO Financial's (CNO) solid financial health continues to impress, rising level of debt weighs on the bottom line.
Aon's Inorganic Growth Impresses, Rising Debt Level a Drag
by Zacks Equity Research
Although Aon plc's (AON) top line grows on organic strategies, continuously rising level of debt weighs on its bottom line.
What Should You Expect From The FOMC Meet?
by Zacks Equity Research
What Should You Expect From The FOMC Meet?
Awaiting the Inevitable Interest Rate Hike
by Mark Vickery
The Fed's slow and steady methodology has taken longer than many had anticipated to reach equilibrium, but we are definitely there now.
MGIC Investment (MTG) Reports Robust November Business Data
by Zacks Equity Research
Driven by declining claim payments and improvement in new business written, MGIC Investment (MTG) posts solid figures for November and is likely to retain the momentum in the future.
Why MetLife (MET) Could Be a Top Value Stock Pick
by Zacks Equity Research
MetLife (MET) is a pretty good value pick, as it has decent revenue metrics to back up its earnings, and is seeing solid earnings estimate revisions as well.
Brown & Brown's Strategic Efforts Impress, Rising Costs Ail
by Zacks Equity Research
Brown & Brown's (BRO) sustained operational performance and a solid capital backup impress but rising expenses bother.
Hartford Financial Streamlines Business With Talcott Sale
by Zacks Equity Research
Hartford Financial's (HIG) Talcott Resolution segment has been underperforming for quite a long time. Divestiture of this unit is expected to improve the company's overall financial health.
Arthur J. Gallagher's Buyout to Boost Brokerage Services
by Zacks Equity Research
Arthur J. Gallagher (AJG) continues with its inorganic growth strategy riding on Weiss Insurance buyout.
Radian (RDN) Shows Potential to Grow: Apt to Buy the Stock?
by Zacks Equity Research
Radian (RDN) holds immense potential on the back of growth projections and favorable fundamentals.